1.Comparison of Multislice Spiral CT Dual Phase and Somatosatatin Receptor Scintigraphy in the Diagnosis of Pancreas Neuroendocrine Tumors.
Hui WANG ; Ping LI ; Wei-dong PAN ; Hua-dan XUE
Acta Academiae Medicinae Sinicae 2016;38(3):312-317
Objective To compare the sensitivity of multislice spiral CT dual phase and somatosatatin receptor scintigraphy (SRS) in the diagnosis of pancreas nuroendocrine tumors (pNET). Methods Totally 28 patients with pathologically confirmed pNET recieved both CT dual phase contrast and SRS and the results were compared. Results Of these 28 pNET patients,26 (92.8%) were accurately diagnosed by CT dual-phase scan and 20 (71.4%) by SRS (P=0.031).In the functioning pNET cases,the diagnosis sensitivity of CT dual phase scan and SRS was 94.1% (16/17)and 58.8% (10/17)(P=0.218). In the non-functioning pNET cases,the sensitivity was 90.9% (10/11) and 90.9% (10/11) (P=0.740).Diagnostic sensitivity of CT dual phase scan and SRS for pNET without metastasis was 90.4% (19/21) and 57.1% (12/21) (P=0.125).The sensitivity for pNET with metastasis was 100%(7/7)and 100% (7/7). Corresponding to the pathological grading,the diagnostic sensitivity of CT dual phase scanning and SRS was 84.6% (11/13) and 53.8% (7/13) for G1,100% (12/12) and 83.3% (10/12) for G2,and 100% (3/3) and 100% (3/3) for G3. The diagnostic sensitivity of CT dual phase scan and SRS for pNET with diameter less than or equal to 2.0 cm was 94.7% (18/19) and 52.6% (10/19) (P=0.008). For pNET with diameter more than 2.0 cm,the sensitivity was 92.8% (13/14) and 100% (14/14). Conclusions Compared with SRS,dual phase CT scan is more sensitive in diagnosing pNET,especially for those in lower pathological stages. For lesions sized less than or equal to 2.0 cm,SRS should be combined with other imaging examinations to minimize false negative results.
Humans
;
Neuroendocrine Tumors
;
diagnostic imaging
;
Pancreatic Neoplasms
;
diagnostic imaging
;
Radionuclide Imaging
;
Sensitivity and Specificity
;
Tomography, Spiral Computed
2.A Case of Intrapancreatic Accessory Spleen Mistaken as a Pancreatic Mass due to Different Enhancing Pattern from Normal Spleen.
Jun Seok PARK ; Wan Jung KIM ; Yeong Gyu JEONG ; Youn Sun PARK ; Hyun Cheol KOO ; Tae Il LEE ; Gyo Chang CHOI ; Sook KIM
The Korean Journal of Gastroenterology 2011;58(6):357-360
Most cases of accessory spleen show similar features as normal spleen in imaging studies. However, some accessory spleen has unusual scan feature which can be misdiagnosed. We present a case of intrapancreatic accessory spleen that was discovered incidentally during a workup for abdominal pain in a 47-year-old woman. CT and MRI revealed a different enhancing pattern from that of the spleen. Further evaluation with endoscopic ultrasonography failed to identify the pancreatic mass. Therefore, it was surgically removed and diagnosed pathologically as an accessory spleen.
Diagnostic Errors
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Middle Aged
;
Pancreatectomy
;
Pancreatic Neoplasms/radionuclide imaging/surgery/ultrasonography
;
Spleen/*pathology/radionuclide imaging/surgery
;
Tomography, X-Ray Computed
3.A Case of Pancreatic Neuroendocrine Tumor with Multiple Hepatic Metastasis.
Chang Hwan PARK ; Sung Kyu CHOI
The Korean Journal of Gastroenterology 2010;55(5):275-278
No abstract available.
Aged
;
Fluorodeoxyglucose F18/diagnostic use
;
Humans
;
Liver Neoplasms/*diagnosis/pathology/secondary
;
Magnetic Resonance Imaging
;
Male
;
Neuroendocrine Tumors/*diagnosis/radionuclide imaging/secondary
;
Pancreatic Neoplasms/*diagnosis/pathology/radionuclide imaging
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
4.A Case of Pancreatic Neuroendocrine Tumor with Multiple Hepatic Metastasis.
Chang Hwan PARK ; Sung Kyu CHOI
The Korean Journal of Gastroenterology 2010;55(5):275-278
No abstract available.
Aged
;
Fluorodeoxyglucose F18/diagnostic use
;
Humans
;
Liver Neoplasms/*diagnosis/pathology/secondary
;
Magnetic Resonance Imaging
;
Male
;
Neuroendocrine Tumors/*diagnosis/radionuclide imaging/secondary
;
Pancreatic Neoplasms/*diagnosis/pathology/radionuclide imaging
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
5.Prospective comparison of ultrasonography, helical computed tomography, magnetic resonance imaging, and endoscopic ultrasonography in assessing locoregional invasion of primary pancreatic carcinoma.
Yan-Tao TIAN ; Cheng-Feng WANG ; Xin-Ming ZHAO ; Gui-Qi WANG ; Yang-Han OU ; Yu-Zhi HAO ; Yan CHEN ; Hong-Mei ZHANG ; Ping ZHAO
Chinese Journal of Oncology 2008;30(4):270-273
OBJECTIVETo evaluate prospectively the efficacy and clinical significance of ultrasonography (US), helical computed tomography (HCT), endoscopic ultrasonography (EUS) and magnetic resonance imaging (MRI) in assessing locoregional invasion to the surrounding tissue or organs of primary pancreatic carcinoma.
METHODSSixty-eight consecutive patients with pancreatic carcinoma underwent US, HCT, EUS and MRI examinations before surgical exploration. All imaging results in terms of tumor size and locoregional invasion were assessed separately by two diagnostic radiologists and compared with the surgical and pathological findings.
RESULTSAmong the HCT, US, EUS and MRI examinations, EUS had the highest accuracy in assessing tumor size with a regression coefficient for the maximal and minimal diameter of 1.0250 (P = 0.0426) and 0.9873 (P < 0.0001), respectively. In the assessment of locoregional invasion to the surrounding tissue or organs, EUS also had the highest accuracy (75.8%) and sensitivity (80.0%), but MRI had the highest positive predicting value (97.4%). None of these four imaging techniques was significantly correlated with the surgical findings when analyzed by univariate logistic regression.
CONCLUSIONEndoscopic ultrasonography may be the most useful imaging technique in assessing tumor size, but for assessing loco-regional invasion of primary pancreatic carcinoma, combination of more than one imaging techniques may be necessary.
Adult ; Aged ; Diagnostic Imaging ; methods ; Endosonography ; Female ; Humans ; Logistic Models ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Invasiveness ; pathology ; Pancreatic Neoplasms ; diagnostic imaging ; pathology ; surgery ; Prospective Studies ; Radionuclide Imaging ; Tomography, Spiral Computed ; Tumor Burden
6.Differentiation of malignant from benign pancreatic mass by Tl-201 abdominal SPECT.
Hee Seung BOM ; Ho Chun SONG ; Ji Yeul KIM ; Sung Kyu CHOI ; Jong Sun REW ; Chong Mann YOON
Journal of Korean Medical Science 1995;10(2):93-96
The aim of the present study was to evaluate the ability of Tl-201 abdominal SPECT to differentiate between chronic focal pancreatitis and pancreatic malignancy. Seventeen patients (12 men, 5 women; mean age, 56 years; 9 pancreatic cancer, 8 chronic pancreatitis) with pancreatic mass were prospectively investigated with Tl-201 abdominal SPECT. In all patients, CT and/or US could not clarify the nature of the pancreatic mass. Focal hot uptake was present in 8 of 9 patients with pancreatic cancer, while it was present in 2 of 8 patients with chronic pancreatitis. Therefore, the sensitivity and specificity of the present study were 89% and 75%, respectively. A significant difference of Tl-201 uptakes was noted between benign and malignant masses (p& 0.05). Therefore, we concluded that Tl-201 abdominal SPECT was a useful test in differentiation of malignant from benign pancreatic mass, especially when the differentiation could not be made by other imaging modalities
Abdomen/*radionuclide imaging
;
Chronic Disease
;
Diagnosis, Differential
;
Evaluation Studies
;
Female
;
Follow-Up Studies
;
Human
;
Male
;
Middle Age
;
Pancreatic Neoplasms/*radionuclide imaging
;
Pancreatitis/*radionuclide imaging
;
Prospective Studies
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Support, Non-U.S. Gov't
;
Thallium Radioisotopes/*diagnostic use
;
Tomography, Emission-Computed, Single-Photon/methods
7.Preliminary efficacy of CyberKnife radiosurgery for locally advanced pancreatic cancer.
Ze-Tian SHEN ; Xin-Hu WU ; Bing LI ; Lei WANG ; Xi-Xu ZHU
Chinese Journal of Cancer 2010;29(9):802-809
BACKGROUND AND OBJECTIVECybeKnife is a newly developed technology in the field of stereotactic radiosurgery/radiotherapy (SRS/SRT). Compared with conventional SRS/SRT, there are many advantages for CyberKnife in terms of treating tumors that move with respiration, being real-time image-guidance, frameless, high accurateness, and so on. Recently, it has been used to treat different types of malignant carcinoma including intracranial and caudomedial tumors. This study was designed to evaluate the short-term efficacy and toxicity of the CyberKnife radiotherapy for locally advanced pancreatic cancer.
METHODSA total of 20 patients with locally advanced (stage II-III) pancreatic cancer treated with CyberKnife were recruited between April 2009 and December 2009. Of 20 patients, 13 were with cancer located at the pancreatic head and 7 were located at the pancreatic body and tail. The planning target volume (PTV) was defined as gross tumor volume (GTV) plus 2-3 mm, and more than 95% PTV should be covered by 75% isodose surface. The median of PTV was 47 cm³ (26-64 cm³). The median total prescription dose was 40 Gy (32-55 Gy) at 3-6 fractions. During treatment delivery, X-Sight Spine Tracking System was used in 5 patients to track movement of the tumor. Other 15 patients were implanted fiducials in the tumors to track movement of the tumor and patient breathing patterns.
RESULTSThe median follow-up time was 7 months (3-11 months). All patients had finished the treatment and 19 were alive by the last follow-up. Slight fatigue was the most common complain. Evaluated by CT scan, 6 were complete response, 9 were partial response, 3 were stable disease, and 1 was progression; 1 was dead. There were 6 patients with grade I granulocytopenia, 7 with grade I nausea, and 5 with grade II vomiting.
CONCLUSIONSThe CyberKnife radiosurgery for the locally advanced pancreatic cancer shows a high rate of local control and minimal toxicity. Long-term follow-up is necessary to evaluate the survival and late toxicity.
Adult ; Aged ; CA-19-9 Antigen ; blood ; Female ; Follow-Up Studies ; Humans ; Leukopenia ; etiology ; Male ; Middle Aged ; Nausea ; etiology ; Neoplasm Staging ; Pancreatic Neoplasms ; diagnostic imaging ; surgery ; Quality of Life ; Radionuclide Imaging ; Radiosurgery ; adverse effects ; Radiotherapy Dosage ; Remission Induction ; Thrombocytopenia ; etiology
8.Expression of somatostatin receptor reporter gene and its correlation with targeted imaging in vivo for detection of pancreas carcinoma.
Zi-zheng WANG ; Wei QU ; Feng WANG ; Yan LI ; Shu-kui WANG ; Jia-qiong WANG
Chinese Journal of Oncology 2005;27(11):663-666
OBJECTIVETo evaluate the value of (99 m)Tc-sandostatin scintigraphy in targeted diagnosis of pancreas carcinoma and the correlation with expression of somatostatin receptor (SSTR) reporter gene in tumor tissue.
METHODSNude mice bearing human pancreas carcinoma xenograft were established in advance. (99 m)Tc-sandostatin imaging was performed in 18 nude mice and tumor to normal tissue ratio (T/NT) was calculated. mRNA expression of SSTR1, SSTR2 and SSTR5 in tumor tissue was detected by RT-PCR.
RESULTSOut of 18 nude mice, 13 mice showed intense uptake of (99 m)Tc-sandostatin. Six hours after (99 m)Tc-sandostatin administration, the T/NT ratio was 2.53 +/- 0.84. Five mice showed negative findings, and the T/NT ratio was 1.04 +/- 0.06. Positive correlations were obtained between the T/NT ratio and the expression of SSTR1 and SSTR2 mRNA, especially SSTR2 (r = 0.807, P < 0.01).
CONCLUSIONHigh expression of SSTR1, SSTR2 and SSTR5 mRNA were found in human pancreas tumor xenograft in nude mice, especially SSTR2. There is a significant correlation between the tumor uptake of (99 m)Tc-sandostatin and SSTR2 mRNA level. This approach may allow SSTR-targeted diagnosis and therapy of human pancreas cancer.
Animals ; Genes, Reporter ; genetics ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Octreotide ; analogs & derivatives ; Organotechnetium Compounds ; Pancreatic Neoplasms ; diagnostic imaging ; genetics ; metabolism ; RNA, Messenger ; biosynthesis ; genetics ; Radionuclide Imaging ; Receptors, Somatostatin ; biosynthesis ; genetics ; Tumor Cells, Cultured